BioMarin Reports One Oral, Seven Poster Presentations at ACMGG Annual Meeting
March 30, 2015 at 09:07 AM EDT
BioMarin Pharmaceutical Inc. (Nasdaq: BMRN) today announced the results of a post-hoc sub-analysis of the PKU-016 or ASCEND study, the ...